Singapore markets closed

GoHealth, Inc. (GOCO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
10.01-0.13 (-1.28%)
As of 10:24AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 97.76M
Enterprise value 599.30M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.13
Price/book (mrq)0.42
Enterprise value/revenue 0.82
Enterprise value/EBITDA 24.86

Trading information

Stock price history

Beta (5Y monthly) 1.78
52-week change 332.03%
S&P500 52-week change 325.01%
52-week high 322.85
52-week low 37.05
50-day moving average 311.52
200-day moving average 313.98

Share statistics

Avg vol (3-month) 315.13k
Avg vol (10-day) 315.42k
Shares outstanding 59.7M
Implied shares outstanding 622.52M
Float 84.6M
% held by insiders 116.08%
% held by institutions 156.08%
Shares short (28 Mar 2024) 4223.39k
Short ratio (28 Mar 2024) 410.59
Short % of float (28 Mar 2024) 44.78%
Short % of shares outstanding (28 Mar 2024) 42.30%
Shares short (prior month 29 Feb 2024) 4214.23k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 318 Nov 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -8.61%
Operating margin (ttm)9.06%

Management effectiveness

Return on assets (ttm)-2.73%
Return on equity (ttm)-28.91%

Income statement

Revenue (ttm)734.67M
Revenue per share (ttm)79.07
Quarterly revenue growth (yoy)298.80%
Gross profit (ttm)N/A
EBITDA 28.95M
Net income avi to common (ttm)-66.82M
Diluted EPS (ttm)-7.19
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)90.81M
Total cash per share (mrq)9.36
Total debt (mrq)543.05M
Total debt/equity (mrq)119.36%
Current ratio (mrq)1.29
Book value per share (mrq)23.94

Cash flow statement

Operating cash flow (ttm)109.14M
Levered free cash flow (ttm)78.7M